Denmark

NORDIC REGIONAL OFFICE

Ordnung

Codan Huset

Gl. Kongevej 60,

DK-1850 Frederiksberg

Phone: +46 8 505 718 00 +46 8 505 718 00

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Grants to HCOs registered in Denmark

Description	Recipient	Type of grant	Purpose	Timeframe	Amount funded DKK	Extent, content and estimated value of the benefit in kind
Becoming and being a mother living with HIV – a multicenter longitudinal mixed methods study	Amager & Hvidovre Hospital, Dep. of Infectious Diseases, Copenhagen Univ. Hospital	Research Grant	Research study to investigate psychosocial outcomes and experiences of women living with HIV during pregnancy and early motherhood	Date; Jan 2021 – Dec 2022	427 500 DKK	N/A
Pathobiology guided therapy in immune-mediated inflammatory arthritis: study using ex vivo models	Aarhus University Hospital, Department of Biomedicine, Health	Research Grant	Research to provide novel insights into the molecular heterogeneity of immune-medicated arthritis and possibly identify markers for less impersonal treatment strategies	Date: Jan 2021 – Dec 2022	250 000 DKK	N/A
Updated estimate of hepatitis B and C prevalence	Odense University Hospital, Department of Infectious diseases	Research Grant	Estimate prevalence of HCV and HBV in DK	Date: Jan 2021 – Dec 2022	70 000 DKK	N/A

Gilead has not provided support to any patient organization from Denmark in 2020. The information is correct at the time of writing (March 2021). The information is subject to change and periodic updates. For a listing of previous years’ payments, click here

This page is intended for visitors outside of the United States.